TELA Bio - Surgical Reconstruction CompanyTELA Bio - Surgical Reconstruction Company Menu

News

APR 16
2018

TELA Bio Announces Series B Investment by Checkmate Capital

READ MORE
MAR 26
2018

TELA Bio Announces Investment Agreement with ProMedica Innovations Venture Fund

READ MORE
MAR 12
2018

TELA Bio Announces Results from Retrospective Study of OviTex® Reinforced BioScaffolds for Abdominal Wall Reconstruction

READ MORE
OCT 30
2017

TELA Bio Announces Hiring of Greg Firestone as Vice President of Strategic Customer Relations

READ MORE
OCT 25
2017

Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement

READ MORE
JUN 5
2017

TELA Bio to Present Surgeon Feedback from Initial Clinical Experience with OviTex™ Reinforced BioScaffolds and Product Permeability Data at Abdominal Wall Reconstruction Conference

READ MORE
APR 25
2017

TELA Bio Initiates BRAVO Study of OviTex™ Reinforced BioScaffolds for Hernia Repair

READ MORE
MAR 31
2017

TELA Bio to Participate in 16th Annual Needham Healthcare Conference

READ MORE
NOV 21
2016

TELA Bio Announces Settlement of Litigation with LifeCell

READ MORE
NOV 1
2016

TELA Bio Announces OviTex™ Reinforced BioScaffolds Implanted in 100 Hernia Repair Procedures

READ MORE
JUL 13
2016

TELA Bio Announces Commercial Launch of OviTex™ Reinforced BioScaffolds for Ventral Hernia Repair and Abdominal Wall Reconstruction

READ MORE
JUN 15
2016

Results From Studies of OviTex™ Reinforced BioScaffolds Presented at Abdominal Wall Reconstruction Conference

READ MORE